Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 5 of 5 entries
View as:

Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05762471 Org: User:
Start: 01/09/23 End: 04/11/24 Due: 04/11/25

A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of GSBR-1290 in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Phase: N/A Priority: Normal
NCT ID: NCT06693843 Org: User:
Start: 10/17/24 End: 11/30/25 Due: 11/30/26

A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05893043 Org: User:
Start: 04/24/23 End: 06/28/23 Due: 06/28/24

A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06139055 Org: User:
Start: 10/02/23 End: 03/31/24 Due: 03/31/25

A Dose-Range Study of GSBR-1290 in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Phase: N/A Priority: Normal
NCT ID: NCT06703021 Org: User:
Start: 12/20/24 End: 11/30/25 Due: 11/30/26